Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 34Insulin Resistance 6Infertility 5Hyperandrogenism 3Anovulation 3Pre-Eclampsia 2Metabolic Syndrome 2Infertility, Female 2Glucose Intolerance 2Diabetes, Gestational 2Carcinoma, Non-Small-Cell Lung 2Weight Loss 1Thyroid Nodule 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Premature Birth 1Precancerous Conditions 1Periodontitis 1Oligomenorrhea 1Lung Neoplasms 1Inflammation 1Colonic Neoplasms 1Amenorrhea 1

Interventions

Fluorouracil 218Leucovorin 201Oxaliplatin 191Irinotecan 148Bevacizumab 107Capecitabine 93Cetuximab 89Folfox protocol 54Chemotherapy, Adjuvant 34Panitumumab 30pembrolizumab 23Nivolumab 22Colonoscopy 22Gemcitabine 20Magnetic Resonance Spectroscopy 19Floxuridine 19IFL protocol 18Celecoxib 18Radiotherapy 17Neoadjuvant Therapy 17Early Intervention, Educational 17Drug Therapy 17Laparoscopy 14Cyclophosphamide 14Counseling 14trifluridine tipiracil drug combination 13regorafenib 13XELOX 13Exercise 13Erlotinib Hydrochloride 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Colonic Neoplasms × Inositol × Clear all
NCT01111292 2016-07-12

Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia

National Cancer Institute (NCI)

Phase 1/2 Terminated
5 enrolled 7 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡